Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Maternal risk factors associated with offspring biliary atresia: population-based study.

Authors:
Ching-Min Chang Kuang-Che Kuo Wan-Hsuan Chen Chung-Hao Su Chuan-Pin Lee Ko-Jung Chen Yao-Hsu Yang Ju-Bei Yen Jiunn-Ming Sheen

Pediatr Res 2022 Jun 27. Epub 2022 Jun 27.

Department of Pediatrics, Chiayi Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Chiayi, Taiwan.

Background: Biliary atresia (BA) is a progressive, idiopathic, fibro-obliterative disease of the intra and extrahepatic biliary tree. If untreated, it results in severe liver injury and death. The etiology and pathogenesis of BA remain unclear. Few studies have investigated the association between maternal illness/drug use and the occurrence of BA in offspring.

Methods: We used the data from the Birth Certificate Application of Taiwan and linked to National Health Insurance Research Database and Taiwan Maternal and Child Health Database for the years 2004 to 2017 (N = 1,647,231) on 2022/03, and identified BA cases according to diagnosis and procedure code. A total of 285 BA cases were identified.

Results: Mothers with type 2 diabetes mellitus and non-dependent drug abuse had higher rates having BA children than non-BA children, with an odds ratio of 2.17 (95% confidence interval [CI] = 1.04-4.53) and OR: 3.02 (95% CI = 1.34-6.78), respectively.

Conclusion: These results support the notion that BA occurrence is related to maternal reasons. Further studies should be designed to identify additional maternal and pregnancy risk factors and to understand the underlying pathophysiology.

Impact: 1. The occurrence of offspring biliary atresia may be related to maternal illness/drug use. 2. Maternal drug abuse and type 2 diabetes mellitus pose a high risk for offspring biliary atresia. 3. If maternal etiology is found, biliary atresia might be a preventable disease.

Download full-text PDF

 Source
http://dx.doi.org/10.1038/s41390-022-02166-wDOI Listing
June 2022

Publication Analysis

Top Keywords

biliary atresia
20
offspring biliary
12
type diabetes
8
atresia maternal
8
diabetes mellitus
8
drug abuse
8
maternal illness/drug
8
maternal
8
risk factors
8
biliary
6
atresia
5
higher rates
4
rates children
4
abuse higher
4
children non-ba
4
non-dependent drug
4
mellitus non-dependent
4
non-ba children
4
children odds
4
mothers type
4

Keyword Occurance

Similar Publications

The cholestatic infant: updates on diagnosis and genetics.

Authors:
Andrew Wehrman Christine K Lee

Curr Opin Pediatr 2022 Aug 4. Epub 2022 Aug 4.

Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, Massachusetts, USA.

Purpose Of Review: Cholestasis in infants can indicate a serious hepatobiliary disease and requires timely assessment, diagnosis and intervention to prevent progression to serious liver decompensation. This report aims to highlight recently published studies regarding diagnosis and treatment of cholestasis in infants.

Recent Findings: The evaluation of neonatal cholestasis can be challenging, requiring the assessment of a broad differential diagnosis in timely fashion. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Biochemical Evaluation of Laparoscopic Portoenterostomy for Treating Biliary Atresia and Redo for Failed Portoenterostomy.

Authors:
Takafumi Tsukui Hiroyuki Koga Joel Cazares Shunsuke Yamada Hiroshi Murakami Soichi Shibuya Hiroki Nakamura Takanori Ochi Koichi Tsuboi Geoffrey Lane Nana Tanaka Go Miyano Tadaharu Okazaki Masahiko Urao Atsuyuki Yamataka

J Laparoendosc Adv Surg Tech A 2022 Aug 8. Epub 2022 Aug 8.

Department of Pediatric General and Urogenital Surgery, Juntendo University School of Medicine, Tokyo, Japan.

Postoperative outcomes of portoenterostomy (PE) and redo-PE were evaluated using selected biochemical markers (SBM) and biochemical status categories (BSC). Subjects were 70 consecutive PE performed for biliary atresia. SBM were aspartate aminotransferase (AST)/alanine aminotransferase (ALT), cholinesterase (ChE), and platelet count (PLT) assessed at 1, 2, 3, 6, and 12 months, and thence, annually for a maximum of 10 years. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Neonatal portal thrombosis in biliary atresia after Kasai procedure.

Authors:
Atsushi Harada Masashi Kurobe

Pediatr Int 2022 Jan;64(1):e15262

Division of Pediatric Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.

View Article and Full-Text PDF
January 2022
Similar Publications

Need for transition medicine in pediatric surgery - health related quality of life in adolescents and young adults with congenital malformations.

Authors:
Marie Uecker Benno Ure Julia Hannah Quitmann Jens Dingemann

Innov Surg Sci 2021 Dec 7;6(4):151-160. Epub 2022 Jan 7.

Center of Pediatric Surgery, Hannover Medical School and Bult Children's Hospital, Hannover, Germany.

Survival rates of patients with visceral congenital malformations have increased considerably. However, long-term morbidity in these patients is high. In the last decades, these circumstances have led to a shift in goals of caretakers and researchers with a new focus on patients' perspectives and long-term morbidity. Read More

View Article and Full-Text PDF
December 2021
Similar Publications

Serum Matrix Metalloproteinase 7 as a Diagnostic and Prognostic Biomarker for Extrahepatic Biliary Atresia.

Authors:
Teg Rabab Singh Prabudh Goel Minu Bajpai Devasenathipathy Kandasamy Rohan Malik Rajni Yadav Shyam Prakash Kalaivani Mani Madhavi Tripathi Devendra Kumar Yadav Anjan Kumar Dhua Vishesh Jain Sandeep Agarwala

J Indian Assoc Pediatr Surg 2022 Mar-Apr;27(2):227-235. Epub 2022 Mar 1.

Department of Paediatric Surgery, All India Institute of Medicine Sciences, New Delhi, India.

Background: Differentiation of neonatal cholestasis into neonatal hepatitis (NH) and extrahepatic biliary atresia (EHBA) is essential to formulate the treatment plan; promptness is indispensable for optimal outcomes. The clinical and nonoperative algorithms lack precision; the investigations (liver biopsy or per-operative cholangiogram) are invasive. There is a need for a noninvasive test which is both, sensitive and specific and has a high likelihood ratio. Read More

View Article and Full-Text PDF
March 2022
Similar Publications
}